Exclusive

Publication

Byline

Zydus launches cancer biosimilar nivolumab at steep discount

MUMBAI, Jan. 22 -- Zydus Lifesciences has launched its biosimilar of anti-cancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the ... Read More


Dr Reddy's net profit beats estimates despite 14% dip, set for India semaglutide launch

New Delhi, Jan. 21 -- Hyderabad-based Dr Reddy's Laboratories beat street estimates in the third quarter, reporting revenue of Rs.8,726.8 crore and profit after tax (PAT) of Rs.1,210 crore, with stead... Read More


Pharma Q3 preview: Core business, India growth to offset Revlimid pain

New Delhi, Jan. 15 -- As India's pharmaceutical sector kicks off its earnings season for the quarter ended December on Friday, analysts expect muted margins. A key reason for this is the loss of paten... Read More


Pharma Q3 preview: India growth, base business may offset US headwinds

New Delhi, Jan. 15 -- As India's pharmaceutical sector kicks off its earnings season for the quarter ended December on Friday, analysts expect muted margins. A key reason for this is the loss of paten... Read More


Pee Safe raises $32 million from OrbiMed to accelerate expansion

New Delhi, Jan. 14 -- Pee Safe, a personal hygiene brand, plans to expand its offline and online presence after raising $32 million ( Rs.290 crore) from global healthcare-focused private equity firm O... Read More


The year Indian drug innovation bets started paying off

New Delhi, Jan. 6 -- Dear reader, as 2025, a year of global tumult and volatility, rolls by, Mint's reporters and columnists look around the corner on what is coming in 2026-to help you know what to e... Read More


Obesity drugs may spur licensing, distribution deals for Indian drugmakers after patent expires

New Delhi, Jan. 2 -- The growing popularity of obesity drugs is expected to spur Indian pharma companies to sign licensing partnerships and distribution deals as they eye the lucrative segment. Indian... Read More


Cipla ties up with Pfizer for exclusive marketing of four brands

New Delhi, Dec. 19 -- Pfizer India and Cipla announced a partnership on Friday in which Cipla will exclusively market and distribute four Pfizer brands in India to increase their reach. These include... Read More


Concentric scale-ups: Mid-tier hospitals make expansion bets as large rivals consolidate

New Delhi, Dec. 16 -- Even as large hospitals in India rapidly consolidate, smaller corporate chains are aggressively expanding with an aim to grow into regional leaders - which, experts say, in turn,... Read More


Novo Nordisk launches Ozempic at Rs.2.2k a wk

MUMBAI, Dec. 13 -- Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of Rs.2,200 per week. For a four-week course, the entry 0.25 m... Read More